Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-18

Clinical Trial Update: Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function [Phase 4]

View source ↗

Summary

Phase 4 trial updating neurotoxic adverse effects of morphine and oxycodone in terminal patients with diminished renal function; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Oxycodone (oxycodone)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Pain, Terminal Illness | Phase 4 | Status: TERMINATED